The report was released ahead of an update to federal dietary guidelines coming next year that could include new recommendations about how much alcohol people should drink.
The lawsuit alleges Kaya Clementine Breen, 20, was misdiagnosed with gender dysphoria and rushed into “irreversibly damaging” transition-related treatment and surgery.
The woman was accused of selling counterfeit versions of popular weight loss drugs, including Ozempic and Wegovy. Experts say fakes have exploded in the U.S.